ID 1495 -
L-karnityna
PL: L-karnityna
EN: L-carnitine
Pdf: L-carnitine
1. Charakterystyka żywności / składnika
The food constituent that is the subject of the health claim is carnitine (as L-carnitine).
Carnitine is a quaternary ammonium salt synthesised primarily in the liver and kidneys from amino acids, lysine and methionine. In living cells carnitine is required for the transport of fatty acids from the cytosol into the mitochondria for beta-oxidation. L-carnitine is the form commonly used in food supplements. The content of L-carnitine in foods can be measured by established methods. This opinion refers to the effects of L-carnitine when consumed as food supplements in addition to a protein adequate diet.
The Panel considers that the food constituent, L-carnitine, which is the subject of the health claims, is sufficiently characterised.
2.7. Wzrost stężenia L-karnityny i/lub zmniejszenie stężenia wolnych kwasów tłuszczowych u kobiet w ciąży (ID 1495)
The claimed effect is “pregnancy”. The Panel assumes that the target population is pregnant women.
In the context of the proposed wordings, the Panel assumes that the claimed effect relates to increasing L-carnitine concentrations, and to decreasing free fatty acids, in blood during pregnancy.
The Panel considers that the evidence provided does not establish that increasing L-carnitine concentrations and/or decreasing free fatty acids in blood during pregnancy in the context of a protein adequate diet is a beneficial physiological effect per se.
The Panel concludes that a cause and effect relationship has not been established between the consumption of L-carnitine and a beneficial physiological effect related to increasing L-carnitine concentrations and/or decreasing free fatty acids in blood during pregnancy.
Warunki i możliwe ograniczenia stosowania oświadczenia
Min. 500 mg/day
